Korean Journal of Family Practice

Table. 2.

Ongoing clinical trials of coronavirus disease 2019 (COVID-19) vaccines on children

Vaccine BNT162b2 mRNA-1273 AZD1222 Ad26.COV2.S
Manufacturer Pfizer BioNTech Moderna Oxford AstraZeneca Janssen (J&J)
Ongoing/completed clinical trials on children ∙ Phase 3 (finished): adolescents 12 to 15 y ∙ Phase 2/3 (2021.2~): adolescents 12 to 17 y ∙ Phase 2 (2021.02~): Children ≥6 y ∙ Phase 2a: Adolescents 12 to 17 y
∙ Phase 1/2/3 (2021.3~):6 mo to 11 y ∙ Phase 2/3 (2021.3~): 6 mo to 11 y

Adapted from the article of Kang et al. (Clin Exp Pediatr 2021; 64: 328-38).20)

Korean J Fam Pract 2021;11:236~246 https://doi.org/10.21215/kjfp.2021.11.4.236
© KJFP